Rifapentine-proliposomes for inhalation: in vitro and in vivo toxicity
{{output}}
Background: Oral therapy for pulmonary tuberculosis (TB) treatment suffers from the limitation of hepatic metabolism leading insufficient concentration of antitubercular (anti-TB) drugs in alveolar macrophage which harbors Mycoba... ...
